PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells (Q3298506)

From EU Knowledge Graph
Revision as of 10:17, 19 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q3298506 in Germany
Language Label Description Also known as
English
PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells
Project Q3298506 in Germany

    Statements

    0 references
    0 references
    374,808.26 Euro
    0 references
    749,616.52 Euro
    0 references
    50.0 percent
    0 references
    1 January 2016
    0 references
    31 August 2018
    0 references
    Charité - Universitätsmedizin Berlin Campus Mitte Cecilie-Vogt-Klinik für Molekulare Neurologie
    0 references
    0 references
    0 references

    52°30'5.47"N, 13°24'9.18"E
    0 references
    10117 - Berlin
    0 references
    Erforschung einer neuen Syntheseroute zur Generierung von struktur-reinen Core-Shell-Partikeln, die für die pharmazeutische Produktion geeignet sind, sowie umfassende Charakterisierung der Partikel mit geeigneten Methoden und Validierungsexperimenten in vitro und in vivo im Tiermodell (German)
    0 references
    Research into a new synthesis route for the generation of structurally pure core shell particles suitable for pharmaceutical production as well as comprehensive characterisation of the particles using appropriate methods and validation experiments in vitro and in vivo in the animal model (English)
    24 October 2021
    0 references
    Recherche d’une nouvelle voie de synthèse pour la génération de particules de coquille de base de structure pure, adaptées à la production pharmaceutique, et caractérisation complète des particules par des méthodes et des expériences de validation appropriées in vitro et in vivo dans le modèle animal (French)
    6 December 2021
    0 references
    Onderzoek naar een nieuwe syntheseroute voor het genereren van structureel zuivere kernschildeeltjes die geschikt zijn voor farmaceutische productie, alsmede een uitgebreide karakterisering van de deeltjes met behulp van geschikte methoden en validatie-experimenten in vitro en in vivo in het diermodel (Dutch)
    19 December 2021
    0 references

    Identifiers

    DE_TEMPORARY_1309
    0 references